---
title: Emery Pharma vs NorthEast BioLab
slug_a: emerypharma
slug_b: nebiolab
site: cro
review_signal_gate: closed
canonical_path: /compare/emerypharma/nebiolab
---

# Emery Pharma vs NorthEast BioLab

Side-by-side profile data from each company listing on this directory.

## Emery Pharma

- Profile: [/companies/emerypharma](/companies/emerypharma)

Emery Pharma — Full-service CRO delivering analytical, bioanalytical, and microbiology services across small molecules, biologics, gene therapy, and botanical drugs from discovery through clinical development.

Services: 6. Modalities: 4. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- Bioanalysis
- Regulatory Affairs
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Microbiology Services

### Modalities

- Small Molecule
- Biologics (Other)
- Gene Therapy
- Vaccine

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## NorthEast BioLab

- Profile: [/companies/nebiolab](/companies/nebiolab)

NorthEast BioLab — Bioanalytical CRO providing PK/PD, immunogenicity (ADA/nAb), cytokine, and biomarker assays across LC-MS, Meso Scale Discovery, ELISA, and ddPCR platforms. Operates GLP/GCLP-compliant facilities and reports DEA and CT approval for Schedule I–IV bioanalysis.

Services: 13. Modalities: 6. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (13).

### Services

- In Vitro ADME / DMPK
- Preclinical In Vivo Studies
- In Vivo PK / PD Studies
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Clinical Trial Services
- Central Laboratory Services
- Analytical Method Development & Validation
- ICH Stability Studies

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Data not yet provided.